One advantage of the GLP-1 receptor agonists in relation to obesity is that they play a significant role in inducing insulin secretion after meals and aid in weight loss by encouraging satiety and delaying stomach emptying [11-13]. This evidence concerns the gene GLP1R and obesity disorder.